AR061262A1 - METHOD FOR TREATMENT OF RESPIRATORY DISORDERS USE OF AN ANTIBIOTIC IN THE MANUFACTURE OF AN AEROSOL AND COMPOSITION OF ANTIBIOTIC IN AEROSOL - Google Patents

METHOD FOR TREATMENT OF RESPIRATORY DISORDERS USE OF AN ANTIBIOTIC IN THE MANUFACTURE OF AN AEROSOL AND COMPOSITION OF ANTIBIOTIC IN AEROSOL

Info

Publication number
AR061262A1
AR061262A1 ARP070102453A ARP070102453A AR061262A1 AR 061262 A1 AR061262 A1 AR 061262A1 AR P070102453 A ARP070102453 A AR P070102453A AR P070102453 A ARP070102453 A AR P070102453A AR 061262 A1 AR061262 A1 AR 061262A1
Authority
AR
Argentina
Prior art keywords
aerosol
antibiotic
respiratory disorders
manufacture
treatment
Prior art date
Application number
ARP070102453A
Other languages
Spanish (es)
Inventor
Hanumantharao Tatapudy
Syed M Shah
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of AR061262A1 publication Critical patent/AR061262A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Abstract

Un método para tratar trastorno respiratorios que comprenden administrar un antibiotico en aerosol a un mamífero por vía de un sistema de suministro de droga en aerosol, caracterizado porque el sistema de suministro de drogas en aerosol produce un tamano de partícula en aerosol de 1 a 3 micrometros para al menos 90% de las partículas, y porque el antibiotico comprende ZOSYN, Piperacilina, Tazobactam o TYGACIL.A method of treating respiratory disorders comprising administering an aerosol antibiotic to a mammal via an aerosol drug delivery system, characterized in that the aerosol drug delivery system produces an aerosol particle size of 1 to 3 micrometers. for at least 90% of the particles, and because the antibiotic comprises ZOSYN, Piperacillin, Tazobactam or TYGACIL.

ARP070102453A 2006-06-07 2007-06-07 METHOD FOR TREATMENT OF RESPIRATORY DISORDERS USE OF AN ANTIBIOTIC IN THE MANUFACTURE OF AN AEROSOL AND COMPOSITION OF ANTIBIOTIC IN AEROSOL AR061262A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81167206P 2006-06-07 2006-06-07

Publications (1)

Publication Number Publication Date
AR061262A1 true AR061262A1 (en) 2008-08-13

Family

ID=38508902

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070102453A AR061262A1 (en) 2006-06-07 2007-06-07 METHOD FOR TREATMENT OF RESPIRATORY DISORDERS USE OF AN ANTIBIOTIC IN THE MANUFACTURE OF AN AEROSOL AND COMPOSITION OF ANTIBIOTIC IN AEROSOL

Country Status (4)

Country Link
AR (1) AR061262A1 (en)
PE (1) PE20080329A1 (en)
TW (1) TW200815002A (en)
WO (1) WO2007145868A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102641249A (en) * 2012-05-06 2012-08-22 江苏奥赛康药业股份有限公司 Preparation method of tigecycline composition
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
AU2014227660B2 (en) 2013-03-15 2014-11-06 Merck Sharp & Dohme Llc Ceftolozane antibiotic compositions
US20140274991A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane
WO2020239696A1 (en) * 2019-05-24 2020-12-03 Stichting Katholieke Universiteit Improved administration of glycylcyclines by inhalation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508269A (en) * 1994-10-19 1996-04-16 Pathogenesis Corporation Aminoglycoside formulation for aerosolization
US5611332A (en) * 1995-03-22 1997-03-18 Bono; Michael Aerosol inhalation device containing a rain-off chamber
GB0004531D0 (en) * 2000-02-25 2000-04-19 Richards Andrew J M The treatment of respiratory diseases
US20030051728A1 (en) * 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
AU2003225689B2 (en) * 2002-03-05 2009-03-26 Transave, Inc. Methods for entrapment of bioactive agent in a liposome or lipid complex

Also Published As

Publication number Publication date
WO2007145868A1 (en) 2007-12-21
PE20080329A1 (en) 2008-04-09
TW200815002A (en) 2008-04-01

Similar Documents

Publication Publication Date Title
AR061262A1 (en) METHOD FOR TREATMENT OF RESPIRATORY DISORDERS USE OF AN ANTIBIOTIC IN THE MANUFACTURE OF AN AEROSOL AND COMPOSITION OF ANTIBIOTIC IN AEROSOL
CY1122807T1 (en) COMPOSITIONS, METHODS AND SYSTEMS FOR ADMINISTERING TWO OR MORE ACTIVE AGENTS THROUGH THE RESPIRATORY TRACT
NZ573555A (en) Nanoparticulate posaconazole formulations
CL2008001966A1 (en) Oral dissolution composition comprising lamotrigine, in the form of lamotrigine particles coated with a taste-masking layer and granules comprising a disinfectant and a sugar alcohol and / or a carbohydrate; method of preparation, use to treat mood disorders and prevention of attacks.
CO2018011051A2 (en) Dosage forms of modified release deterrents of abuse
NO20092527L (en) Promotional products, method of manufacture and use thereof
AR053026A1 (en) COMPOSITIONS OF ANTIBODIES ANTI FACTOR OF STIMULATION OF COLONIES OF MACROFAGOS (ANTI-M CSF)
CL2018001420A1 (en) Treatment of cognitive disorders with (r) -7-chloro-n- (quinuclidin-3-yl) benzo [b] thiophene-2-carboxamide and pharmaceutically acceptable salts thereof. (divisional application 201701853)
BRPI0806392A8 (en) use of aclidinium, aclidinium, treatment or prevention method and pharmaceutical composition
BRPI0603073A (en) Method for delivering drugs to micro-jet propelled tissue
AR058194A1 (en) DRUGS THAT INCLUDE AN ANTIMUSCARINIC AGENT AND A CORTICOESTEROID
BRPI0705488A (en) stable nanoparticulate composition, methods of preparing it and preventing and / or treating a bacterial infection, pharmaceutical composition, and dosage form
TW200642704A (en) Oral drug delivery system and methods of use thereof
CO6361899A2 (en) INHALABLE PARTICLES THAT INCLUDE TIOTROPIO
RS52867B (en) Combination therapy with glatiramer acetate and rasagiline for the treatment of multiple sclerosis
CL2013002033A1 (en) Oral rapid disintegration preparation comprising granules comprising a medicament, a disintegrating agent, a binder, a masking agent and a solubilizing agent; Preparation method; its use for the prophylaxis and / or treatment of a bipolar condition.
AR057904A1 (en) MEDICATIONS THAT INCLUDE AN ANTIMUSCERINIC AGENT AND A CORTICOESTEROID
MX2009000849A (en) Orally dissolvable/disintegrable lyophilized dosage forms containing protected particles.
ATE505203T1 (en) PHARMACEUTICAL COMBINATION OF ALISKIREN AND VALSARTAN
AR061263A1 (en) METHOD TO TREAT RESPIRATORY DISORDERS
EA200802350A3 (en) DRUG DELIVERY SYSTEM
BR0312619A (en) Pharmaceutical composition, method for formulating a modafinil composition, pharmaceutical dosage unit, and methods for altering the sleepy state of a mammal, enhancing the activity condition or increasing the regularity of sleep periodicity
BR112013029149A2 (en) inorganic particulate material production process
CR9200A (en) USE OF A 5-HT6 AGONIST FOR THE TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISORDERS
PH12015502274A1 (en) Lozenge for treating a sore throat, hoarseness, and associated dry cough and for treating inflammatory diseases of the oral cavity and of the pharynx

Legal Events

Date Code Title Description
FB Suspension of granting procedure